B2M.md
... ...
@@ -20,12 +20,7 @@ B2M mutations in B-cell lymphomas, particularly in DLBCL and PMBCL, lead to redu
20 20
21 21
## Relevance tier by entity
22 22
23
-|Entity|Tier|Description |
24
-|:------:|:----:|---------------------------------------|
25
-|![PMBL](images/icons/PMBL_tier1.png)|1 |high-confidence PMBL/cHL/GZL gene[@reichelFlowSortingExome2015]|
26
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@morinFrequentMutationHistonemodifying2011] |
27
-|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene[@morinFrequentMutationHistonemodifying2011] |
28
-|![MCL](images/icons/MCL_tier2.png) |2 |relevance in MCL not firmly established[@pararajalingamCodingNoncodingDrivers2020]|
23
+[[include:table1_B2M.md]]
29 24
30 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 26